(Q54710973)
Statements
Abiraterone acetate in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer: U.S. Food and Drug Administration drug approval summary. (English)
1 reference
Paul G Kluetz
1 reference
Yang-Min Ning
1 reference
V Ellen Maher
1 reference
Lijun Zhang
1 reference
Shenghui Tang
1 reference
Debasis Ghosh
1 reference
Robeena Aziz
1 reference
Todd Palmby
1 reference
Elimika Pfuma
1 reference
Jeanne Fourie Zirkelbach
1 reference
Nitin Mehrotra
1 reference
Amy Tilley
1 reference
Rajeshwari Sridhara
1 reference
Amna Ibrahim
1 reference
Robert Justice
1 reference
Richard Pazdur
1 reference
22 October 2013
1 reference
19
1 reference
6650-6656
1 reference
24
1 reference
Identifiers
1 reference